• Investor → «Catalio Capital Management»

Catalio Capital Management Investor

Catalio Capital Management is a venture capital firm that invests in breakthrough biomedical technology companies. It was created by George Petrocheilos and Dr. Jacob Vogelstein in 2020.


Invests into

  • Anagenex Anagenex
  • Armour (Global) Ltd Armour (Global) Ltd
  • Cambrian Biopharma Cambrian Biopharma
  • Capital Management Capital Management
  • Celsius Therapeutics Celsius Therapeutics
  • Centara Labs (was Rejuveron) Centara Labs (was Rejuveron)
  • Enveda Biosciences Enveda Biosciences
  • Freenome Freenome
  • Glympse Bio Glympse Bio
  • Hyperfine Hyperfine
  • Immunai Immunai
  • Metagenomi Metagenomi
  • Neumora Therapeutics Neumora Therapeutics
  • Noetik Noetik
  • Odyssey Therapeutics Odyssey Therapeutics
  • Paige Paige
  • Recursion Pharmaceuticals Recursion Pharmaceuticals
  • Savol Wellness & Health Centre Holding Savol Wellness & Health Centre Holding
  • Sensei Biotherapeutics Sensei Biotherapeutics
  • Volastra Therapeutics Volastra Therapeutics
  • Xilis Xilis
  • eGenesis eGenesis

Investors

  • Cambrian Biopharma Cambrian Biopharma
  • Charlie Nettleton Charlie Nettleton
  • Hannah Schwartz Hannah Schwartz
  • Tom Brooks Tom Brooks
Headquarters: United States
Founded Date: 2016.0
Number Of Exists: 8
Investor Type: Venture Capital

Visit Website
View Full Profile
admin@cataliocapital.com
https://www.linkedin.com/company/catalio-capital/
https://twitter.com/CatalioCapital
Register and Claim Ownership